Teijin taps external expertise for strategic pharma direction
This article was originally published in Scrip
Executive Summary
The diversified Japanese group Teijin has decided it needs a bit of outside help in defining a global strategy for its healthcare business. So it has retained the private US firm InCube Labs to advise on issues ranging from growth opportunities to markets and regulations.